21. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study
Sand, Michael, Brown, David, Nakagome, Kazuyuki, Cordes, Joachim, Brenner, Ronald, Gruender, Gerhard, Keefe, Richard, Riesenberg, Robert, Walling, David, Daniels, Kristen, Wang, Lara, McGinniss, JenniVolume:
43
Language:
english
Journal:
Schizophrenia Bulletin
DOI:
10.1093/schbul/sbx021.040
Date:
March, 2017
File:
PDF, 86 KB
english, 2017